Mezzasalma Advisors, LLC Pfizer Inc Transaction History

Mezzasalma Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$26.13 - $33.94 $18,055 - $23,452	-691 Reduced 7.99%	7,957 $229,000
Q3 2023 Nov 16, 2023	BUY	$32.09 - $37.51 $10,814 - $12,640	337 Added 4.05%	8,648 $286,000
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $4,117 - $4,764	114 Added 1.39%	8,311 $304,000
Q4 2022 Feb 28, 2023	SELL	$41.75 - $54.5 $17,117 - $22,345	-410 Reduced 4.76%	8,197 $420,000
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $11,260 - $13,351	242 Added 2.89%	8,607 $451,000
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $11,982 - $17,762	290 Added 3.59%	8,365 $494,000
Q2 2021 Jul 14, 2021	SELL	$35.91 - $40.68 $35,730 - $40,476	-995 Reduced 10.97%	8,075 $316,000
Q1 2021 Jun 01, 2021	SELL	$33.49 - $37.77 $2,009 - $2,266	-60 Reduced 0.66%	9,070 $329,000
Q4 2020 Jun 01, 2021	BUY	$33.47 - $42.56 $305,581 - $388,572	9,130 New	9,130 $336,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Mezzasalma Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mezzasalma Advisors, LLC with notifications on news.